...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Short interest up to Jan 15th 172,877

Starting trials for CKD and Fabry's is going to cost a decent chunk of change....and I don't think they have the money yet.  Its amazing to me that with 5 thumbs up from the DSMB for BETonMACE, validation from Pfizer vis a vis their patent application for the treatment of Friedrich's Ataxia including Apabetalone, the Nature piece and all the other scientific write ups....

With all these positive developments Don still seems to have a hard time raising the needed capital...and when he does succeed in bringing in some financing its always at what I (and others it seems) view as bargain basement prices.  And even then, since the summer....its only been just enough to punt the ball a few yards down the field meaning more money is needed in just another 3 or 4 months or so.

Share
New Message
Please login to post a reply